在治疗白血病的CAR-T疗法中克服抗原逃逸和T细胞耗尽
Elżbieta Bartoszewska1,2, Maciej Tota1,2, Monika Kisielewska1,2
1Faculty of Medicine, Wroclaw Medical University, Mikulicza-Radeckiego 5, 50-345 Wroclaw, Poland.
Cells
|September 27, 2024
概括
化学抗原受体T细胞 (CAR-T) 疗法对白血病有前途,但抗原逃逸和T细胞枯竭等挑战仍然存在. 研究重点是双重向策略和增强CAR-T细胞持久性,以改善结果和降低风险.
科学领域:
- 免疫学 免疫学 免疫学
- 在瘤学瘤学.
- 生物技术是生物技术.
背景情况:
- 白血病仍然是一个重要的儿科癌症,特别是在复发或耐火的情况下.
- 化学抗原受体T细胞 (CAR-T) 治疗提供了一个个性化的方法,通过工程T细胞来对抗癌症.
- 目前的CAR-T疗法面临障碍,包括抗原逃逸和T细胞耗尽.
研究的目的:
- 审查目前针对白血病的CAR-T治疗选择.
- 在CAR-T疗法中应对抗原逃逸和T细胞枯竭等挑战.
- 探索改善CAR-T疗效和安全的策略.
主要方法:
- 关于治疗白血病的CAR-T疗法的文献综述.
- 对双重准策略的分析,以克服抗原损失.
- 检查T细胞耗尽机制和缓解方法.
主要成果:
- 双重准策略显示出防止抗原逃逸的潜力.
- 正在研究提高CAR-T细胞持久性和有效性的方法.
- 卡特-T疗法与细胞因子释放综合征 (CRS) 和神经毒性 (ICANS) 等风险有关.
结论:
- 正在进行的研究对于优化白血病中CAR-T治疗至关重要.
- 减少与CAR-T相关的毒性是发展的关键领域.
- 将CAR-T疗法扩展到其他血液性恶性瘤是未来的目标.
关键词:
在CAR-T疗法中,T细胞耗尽的情况.急性淋巴细胞白血病急性淋巴细胞白血病急性骨髓性白血病 (AML) 是一种急性骨髓性白血病.抗原逃逸的方法是什么?细胞因子释放综合征 细胞因子释放综合征双重定位的CAR-T可以使用.免疫效应细胞相关的神经毒性综合征这种白血病是白血病.儿科瘤学 儿科瘤学更多相关视频
09:12Author Spotlight: Advancements in Hypoxia-Sensitive CAR-T Therapy for Enhanced Cancer Immunotherapy
Published on: June 14, 2024
836
09:34Dynamic Imaging of Chimeric Antigen Receptor T Cells with [18F]Tetrafluoroborate Positron Emission Tomography/Computed Tomography
Published on: February 17, 2022
3.3K
相关概念视频
Tumor Immunotherapy
491
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
491
Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
Treatment Resistant Cancers
3.3K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.3K
Stem Cell Therapy for Tissue Regeneration
4.0K
Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
4.0K
Cell-mediated Immune Responses
67.8K
Overview
67.8K
